Oppenheimer & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $67.9M | Buy |
73,784
+4,417
| +6% | +$4.48M | 0.83% | 15 |
|
|
2025
Q4 | $74.5M | Buy |
69,367
+2,353
| +4% | +$2.25M | 1.06% | 10 |
|
|
2025
Q3 | $51.1M | Sell |
67,014
-5,719
| -8% | -$4.26M | 0.62% | 23 |
|
|
2025
Q2 | $56.7M | Sell |
72,733
-624
| -0.9% | -$485K | 0.75% | 17 |
|
|
2025
Q1 | $60.6M | Buy |
73,357
+674
| +0.9% | +$561K | 0.91% | 14 |
|
|
2024
Q4 | $56.1M | Sell |
72,683
-5,284
| -7% | -$4.38M | 0.84% | 16 |
|
|
2024
Q3 | $69.1M | Sell |
77,967
-1,596
| -2% | -$1.43M | 1.05% | 11 |
|
|
2024
Q2 | $72M | Buy |
79,563
+4,344
| +6% | +$3.47M | 1.14% | 11 |
|
|
2024
Q1 | $58.5M | Buy |
75,219
+2,533
| +3% | +$1.8M | 0.97% | 12 |
|
|
2023
Q4 | $42.4M | Buy |
72,686
+2,702
| +4% | +$1.58M | 0.78% | 15 |
|
|
2023
Q3 | $37.6M | Buy |
69,984
+3,397
| +5% | +$1.75M | 0.78% | 15 |
|
|
2023
Q2 | $31.2M | Sell |
66,587
-825
| -1% | -$346K | 0.62% | 16 |
|
|
2023
Q1 | $23.2M | Sell |
67,412
-5,002
| -7% | -$1.69M | 0.49% | 31 |
|
|
2022
Q4 | $26.5M | Buy |
72,414
+5,520
| +8% | +$1.96M | 0.6% | 21 |
|
|
2022
Q3 | $21.6M | Sell |
66,894
-1,336
| -2% | -$423K | 0.51% | 25 |
|
|
2022
Q2 | $22.1M | Buy |
68,230
+6,194
| +10% | +$1.86M | 0.48% | 35 |
|
|
2022
Q1 | $17.8M | Buy |
62,036
+3,106
| +5% | +$799K | 0.32% | 62 |
|
|
2021
Q4 | $16.3M | Buy |
58,930
+1,737
| +3% | +$440K | 0.28% | 70 |
|
|
2021
Q3 | $13.2M | Sell |
57,193
-4,785
| -8% | -$1.18M | 0.25% | 85 |
|
|
2021
Q2 | $14.2M | Buy |
61,978
+3,592
| +6% | +$722K | 0.26% | 83 |
|
|
2021
Q1 | $10.9M | Sell |
58,386
-24,000
| -29% | -$4.69M | 0.22% | 100 |
|
|
2020
Q4 | $13.9M | Buy |
82,386
+11,150
| +16% | +$1.66M | 0.29% | 74 |
|
|
2020
Q3 | $10.5M | Buy |
71,236
+25,076
| +54% | +$3.88M | 0.26% | 76 |
|
|
2020
Q2 | $7.58M | Sell |
46,160
-2,969
| -6% | -$456K | 0.2% | 104 |
|
|
2020
Q1 | $6.82M | Sell |
49,129
-807
| -2% | -$111K | 0.21% | 102 |
|
|
2019
Q4 | $6.56M | Buy |
49,936
+1,817
| +4% | +$211K | 0.16% | 138 |
|
|
2019
Q3 | $5.38M | Sell |
48,119
-9
| -0% | -$1K | 0.15% | 157 |
|
|
2019
Q2 | $5.33M | Sell |
48,128
-13,724
| -22% | -$1.62M | 0.14% | 160 |
|
|
2019
Q1 | $8.03M | Buy |
61,852
+1,200
| +2% | +$146K | 0.21% | 99 |
|
|
2018
Q4 | $7.02M | Buy |
60,652
+2,162
| +4% | +$242K | 0.22% | 99 |
|
|
2018
Q3 | $6.28M | Buy |
58,490
+1,538
| +3% | +$154K | 0.16% | 141 |
|
|
2018
Q2 | $4.86M | Sell |
56,952
-464
| -0.8% | -$38.1K | 0.13% | 174 |
|
|
2018
Q1 | $4.44M | Buy |
57,416
+3,215
| +6% | +$259K | 0.11% | 194 |
|
|
2017
Q4 | $4.58M | Buy |
54,201
+2,338
| +5% | +$199K | 0.12% | 205 |
|
|
2017
Q3 | $4.44M | Sell |
51,863
-4,725
| -8% | -$388K | 0.12% | 201 |
|
|
2017
Q2 | $4.66M | Sell |
56,588
-9,429
| -14% | -$769K | 0.13% | 190 |
|
|
2017
Q1 | $5.55M | Sell |
66,017
-3,754
| -5% | -$301K | 0.16% | 151 |
|
|
2016
Q4 | $5.13M | Sell |
69,771
-2,366
| -3% | -$176K | 0.15% | 160 |
|
|
2016
Q3 | $5.79M | Buy |
72,137
+2,970
| +4% | +$238K | 0.17% | 139 |
|
|
2016
Q2 | $5.45M | Buy |
69,167
+11,934
| +21% | +$898K | 0.16% | 136 |
|
|
2016
Q1 | $4.12M | Sell |
57,233
-9,821
| -15% | -$743K | 0.13% | 186 |
|
|
2015
Q4 | $5.65M | Buy |
67,054
+6,712
| +11% | +$557K | 0.17% | 139 |
|
|
2015
Q3 | $5.05M | Buy |
60,342
+10,342
| +21% | +$873K | 0.15% | 158 |
|
|
2015
Q2 | $4.17M | Sell |
50,000
-6,093
| -11% | -$464K | 0.12% | 210 |
|
|
2015
Q1 | $4.08M | Sell |
56,093
-22,748
| -29% | -$1.62M | 0.11% | 216 |
|
|
2014
Q4 | $5.44M | Buy |
78,841
+5,728
| +8% | +$387K | 0.16% | 159 |
|
|
2014
Q3 | $4.74M | Sell |
73,113
-45,446
| -38% | -$2.88M | 0.14% | 172 |
|
|
2014
Q2 | $7.37M | Sell |
118,559
-16,863
| -12% | -$1.01M | 0.22% | 111 |
|
|
2014
Q1 | $7.97M | Buy |
135,422
+5,269
| +4% | +$294K | 0.24% | 97 |
|
|
2013
Q4 | $6.64M | Sell |
130,153
-7,854
| -6% | -$393K | 0.21% | 122 |
|
|
2013
Q3 | $6.95M | Buy |
138,007
+13,874
| +11% | +$726K | 0.24% | 99 |
|
|
2013
Q2 | $6.1M | Buy |
+124,133
| New | +$6.75M | 0.24% | 111 |
|
Other funds holding LLY
VCM
VPM
Oppenheimer & Co's LLY Position: Q1 2026 in Review
Oppenheimer & Co increased its Eli Lilly (LLY) stake by 6.4% in Q1 2026, buying an estimated $4.48M and bringing the position to 73,784 shares worth $67.9M. The position accounts for 0.83% of the portfolio, ranked #15.
Oppenheimer & Co first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $74.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Oppenheimer & Co held 73,784 shares of Eli Lilly worth $67.9M as of Q1 2026.
- Oppenheimer & Co bought 4,417 Eli Lilly shares in Q1 2026, an estimated $4.48M.
- Eli Lilly made up 0.83% of Oppenheimer & Co's portfolio in Q1 2026, its #15 holding.
- Oppenheimer & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Oppenheimer & Co's Eli Lilly position peaked at $74.5M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.